REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/27/2026
Back to search
Official data from USPTO
TOXSTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/27/2026
Trademark type
Combined
Nice classes
5
Filing date
06/03/2020
Registration date
07/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2021
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
MICHELI, ANGELA M
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
JETEMA CO., LTD.
Representatives
Benjamin M. Cantor Cantor Colburn LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating cramps; pharmaceutical preparations for treating muscle; pharmaceutical preparations for treating cerebral palsy; pharmaceutical preparations for treating hyperhidrosis; pharmaceutical agents affecting metabolism; bacteria poisons; Pharmaceutical preparations for treating headache; anaesthetics; pharmaceutical preparations for use in the cosmetic fieldmedicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disordersmuscle disordersnerve disordersheadacheswrinklessports injuriesspasmstremors and pain; botulinum toxin for medical use for use in the treatment of neurological disordersmuscle disordersnerve disordersheadacheswrinklessports injuriesspasmstremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for urogenital organs; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations for house pets for injuries and painpharmaceuticals containing botulinum toxin; Cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations in the nature of botulinum toxinbotulinum toxin-haemagglutin complexbotulinum toxin fragments and other derivatives used to treat neurological diseases; Ophthalmic preparations; allergy medications; Chemical preparations for pharmaceutical purposesfor neurological disordersmuscle disordersnerve disordersheadacheswrinklessports injuriesspasmstremors and pain; Pharmaceutical agents for epidermis; drugs for medical purposespharmaceutical preparations for the treatment of neurological disordersmuscle disordersnerve disordersheadacheswrinklessports injuriesspasmstremors and pain; pharmaceutical preparations for skincare in the nature of botulinum toxinbotulinum toxin-haemagglutin complexbotulinum toxin fragments and other derivatives for medical purposes; pharmaceutical preparations for skin care treatment in the nature of botulinum toxinbotulinum toxin-haemagglutin complexbotulinum toxin fragments and other derivatives for medical purposes; medicines for human purposespharmaceutical preparations for the treatment of neurological disordersmuscle disordersnerve disordersheadacheswrinklessports injuriesspasmstremors and pain; Pharmaceutical preparations for orthopedic purposes; pharmaceutical preparations for treating wrinkles; analgesic preparations; medicines for dental purposes; pharmaceutical preparations for treating pain; pharmaceutical preparation for skin care; medicated preparations for skin treatment; pharmaceutical preparations for respiratory organs; preparations for the treatment of burns; preparations for the treatment of scar
Publications
History of USPTO decisions and trademark events.
27 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/01/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/13/2021
FIMP
FINAL DISPOSITION PROCESSED
12/13/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2021
PUBO
PUBLISHED FOR OPPOSITION
05/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/21/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/08/2021
RFNT
REFUSAL PROCESSED BY IB
10/19/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/01/2020
RFRR
REFUSAL PROCESSED BY MPU
10/01/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2020
CNRT
NON-FINAL ACTION WRITTEN
09/10/2020
DOCK
ASSIGNED TO EXAMINER
09/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/06/2020
Continuous trademark protection
Get notified about every new filing that threatens TOXSTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.